GNF SymAtlas + NCI-60 cancer cell lines, comparison of cancers vs non-cancers, human (Su, 2004; Ross, 2000)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
STAT5A
|
ENSG00000126561.12 | signal transducer and activator of transcription 5A |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
STAT5A | hg19_v2_chr17_+_40440481_40440561 | 0.45 | 4.6e-12 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr12_-_15103621 | 21.42 |
ENST00000536592.1
|
ARHGDIB
|
Rho GDP dissociation inhibitor (GDI) beta |
chr3_-_50649192 | 20.59 |
ENST00000443053.2
ENST00000348721.3 |
CISH
|
cytokine inducible SH2-containing protein |
chr3_+_50649302 | 19.98 |
ENST00000446044.1
|
MAPKAPK3
|
mitogen-activated protein kinase-activated protein kinase 3 |
chr6_+_32605195 | 19.32 |
ENST00000374949.2
|
HLA-DQA1
|
major histocompatibility complex, class II, DQ alpha 1 |
chr2_-_89292422 | 18.05 |
ENST00000495489.1
|
IGKV1-8
|
immunoglobulin kappa variable 1-8 |
chr6_+_32407619 | 16.62 |
ENST00000395388.2
ENST00000374982.5 |
HLA-DRA
|
major histocompatibility complex, class II, DR alpha |
chr1_-_36937075 | 16.34 |
ENST00000464465.2
|
CSF3R
|
colony stimulating factor 3 receptor (granulocyte) |
chr19_+_42724423 | 16.25 |
ENST00000301215.3
ENST00000597945.1 |
ZNF526
|
zinc finger protein 526 |
chr2_-_89399845 | 14.00 |
ENST00000479981.1
|
IGKV1-16
|
immunoglobulin kappa variable 1-16 |
chr6_+_33048222 | 13.89 |
ENST00000428835.1
|
HLA-DPB1
|
major histocompatibility complex, class II, DP beta 1 |
chr2_+_90198535 | 13.30 |
ENST00000390276.2
|
IGKV1D-12
|
immunoglobulin kappa variable 1D-12 |
chr12_-_15114603 | 12.98 |
ENST00000228945.4
|
ARHGDIB
|
Rho GDP dissociation inhibitor (GDI) beta |
chr1_+_158801095 | 12.90 |
ENST00000368141.4
|
MNDA
|
myeloid cell nuclear differentiation antigen |
chr4_-_71532339 | 12.06 |
ENST00000254801.4
|
IGJ
|
immunoglobulin J polypeptide, linker protein for immunoglobulin alpha and mu polypeptides |
chr12_-_15114492 | 11.98 |
ENST00000541546.1
|
ARHGDIB
|
Rho GDP dissociation inhibitor (GDI) beta |
chr1_-_36948879 | 11.90 |
ENST00000373106.1
ENST00000373104.1 ENST00000373103.1 |
CSF3R
|
colony stimulating factor 3 receptor (granulocyte) |
chr17_-_76356148 | 11.88 |
ENST00000587578.1
ENST00000330871.2 |
SOCS3
|
suppressor of cytokine signaling 3 |
chr1_+_111415757 | 11.73 |
ENST00000429072.2
ENST00000271324.5 |
CD53
|
CD53 molecule |
chr2_+_90139056 | 11.63 |
ENST00000492446.1
|
IGKV1D-16
|
immunoglobulin kappa variable 1D-16 |
chr1_+_233086326 | 11.17 |
ENST00000366628.5
ENST00000366627.4 |
NTPCR
|
nucleoside-triphosphatase, cancer-related |
chr22_+_23241661 | 11.14 |
ENST00000390322.2
|
IGLJ2
|
immunoglobulin lambda joining 2 |
chr6_+_31582961 | 11.03 |
ENST00000376059.3
ENST00000337917.7 |
AIF1
|
allograft inflammatory factor 1 |
chr19_-_10446449 | 10.10 |
ENST00000592439.1
|
ICAM3
|
intercellular adhesion molecule 3 |
chr5_-_140013275 | 9.91 |
ENST00000512545.1
ENST00000302014.6 ENST00000401743.2 |
CD14
|
CD14 molecule |
chr1_-_159046617 | 9.73 |
ENST00000368130.4
|
AIM2
|
absent in melanoma 2 |
chr5_-_138725560 | 9.66 |
ENST00000412103.2
ENST00000457570.2 |
MZB1
|
marginal zone B and B1 cell-specific protein |
chr5_-_138725594 | 9.61 |
ENST00000302125.8
|
MZB1
|
marginal zone B and B1 cell-specific protein |
chrY_+_15016725 | 9.60 |
ENST00000336079.3
|
DDX3Y
|
DEAD (Asp-Glu-Ala-Asp) box helicase 3, Y-linked |
chr22_+_37257015 | 9.53 |
ENST00000447071.1
ENST00000248899.6 ENST00000397147.4 |
NCF4
|
neutrophil cytosolic factor 4, 40kDa |
chr7_+_74188309 | 9.50 |
ENST00000289473.4
ENST00000433458.1 |
NCF1
|
neutrophil cytosolic factor 1 |
chr2_-_89340242 | 9.42 |
ENST00000480492.1
|
IGKV1-12
|
immunoglobulin kappa variable 1-12 |
chr19_+_18284477 | 9.32 |
ENST00000407280.3
|
IFI30
|
interferon, gamma-inducible protein 30 |
chr17_+_40440481 | 9.13 |
ENST00000590726.2
ENST00000452307.2 ENST00000444283.1 ENST00000588868.1 |
STAT5A
|
signal transducer and activator of transcription 5A |
chr9_-_97402531 | 9.08 |
ENST00000415431.1
|
FBP1
|
fructose-1,6-bisphosphatase 1 |
chr19_-_44809121 | 8.93 |
ENST00000591609.1
ENST00000589799.1 ENST00000291182.4 ENST00000589248.1 |
ZNF235
|
zinc finger protein 235 |
chr7_-_36634181 | 8.86 |
ENST00000538464.1
|
AOAH
|
acyloxyacyl hydrolase (neutrophil) |
chr2_+_17935383 | 8.74 |
ENST00000524465.1
ENST00000381254.2 ENST00000532257.1 |
GEN1
|
GEN1 Holliday junction 5' flap endonuclease |
chr17_-_34207295 | 8.72 |
ENST00000463941.1
ENST00000293272.3 |
CCL5
|
chemokine (C-C motif) ligand 5 |
chr7_-_29186008 | 8.72 |
ENST00000396276.3
ENST00000265394.5 |
CPVL
|
carboxypeptidase, vitellogenic-like |
chr3_+_111260954 | 8.68 |
ENST00000283285.5
|
CD96
|
CD96 molecule |
chr17_-_62084241 | 8.63 |
ENST00000449662.2
|
ICAM2
|
intercellular adhesion molecule 2 |
chr10_-_75571341 | 8.62 |
ENST00000309979.6
|
NDST2
|
N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 2 |
chr2_+_85804614 | 8.61 |
ENST00000263864.5
ENST00000409760.1 |
VAMP8
|
vesicle-associated membrane protein 8 |
chr1_+_158975744 | 8.56 |
ENST00000426592.2
|
IFI16
|
interferon, gamma-inducible protein 16 |
chr10_-_75571566 | 8.52 |
ENST00000299641.4
|
NDST2
|
N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 2 |
chr2_-_175547571 | 8.46 |
ENST00000409415.3
ENST00000359761.3 ENST00000272746.5 |
WIPF1
|
WAS/WASL interacting protein family, member 1 |
chr7_+_80275621 | 8.43 |
ENST00000426978.1
ENST00000432207.1 |
CD36
|
CD36 molecule (thrombospondin receptor) |
chr22_+_23247030 | 8.36 |
ENST00000390324.2
|
IGLJ3
|
immunoglobulin lambda joining 3 |
chr10_-_6622201 | 8.36 |
ENST00000539722.1
ENST00000397176.2 |
PRKCQ
|
protein kinase C, theta |
chr22_-_37640456 | 8.27 |
ENST00000405484.1
ENST00000441619.1 ENST00000406508.1 |
RAC2
|
ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2) |
chr19_+_37407212 | 8.26 |
ENST00000427117.1
ENST00000587130.1 ENST00000333987.7 ENST00000415168.1 ENST00000444991.1 |
ZNF568
|
zinc finger protein 568 |
chr9_-_110251836 | 8.25 |
ENST00000374672.4
|
KLF4
|
Kruppel-like factor 4 (gut) |
chr5_-_169694286 | 8.25 |
ENST00000521416.1
ENST00000520344.1 |
LCP2
|
lymphocyte cytosolic protein 2 (SH2 domain containing leukocyte protein of 76kDa) |
chr22_-_37640277 | 8.23 |
ENST00000401529.3
ENST00000249071.6 |
RAC2
|
ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2) |
chr8_-_6836156 | 8.22 |
ENST00000382679.2
|
DEFA1
|
defensin, alpha 1 |
chr6_+_32605134 | 7.99 |
ENST00000343139.5
ENST00000395363.1 ENST00000496318.1 |
HLA-DQA1
|
major histocompatibility complex, class II, DQ alpha 1 |
chr14_+_21249200 | 7.71 |
ENST00000304677.2
|
RNASE6
|
ribonuclease, RNase A family, k6 |
chr9_-_97402413 | 7.71 |
ENST00000414122.1
|
FBP1
|
fructose-1,6-bisphosphatase 1 |
chr19_-_51875894 | 7.66 |
ENST00000600427.1
ENST00000595217.1 ENST00000221978.5 |
NKG7
|
natural killer cell group 7 sequence |
chr7_-_37026108 | 7.55 |
ENST00000396045.3
|
ELMO1
|
engulfment and cell motility 1 |
chr17_-_29641084 | 7.50 |
ENST00000544462.1
|
EVI2B
|
ecotropic viral integration site 2B |
chr2_+_17935119 | 7.50 |
ENST00000317402.7
|
GEN1
|
GEN1 Holliday junction 5' flap endonuclease |
chr16_-_75498308 | 7.41 |
ENST00000569540.1
|
TMEM170A
|
transmembrane protein 170A |
chrY_+_15016013 | 7.40 |
ENST00000360160.4
ENST00000454054.1 |
DDX3Y
|
DEAD (Asp-Glu-Ala-Asp) box helicase 3, Y-linked |
chr7_+_142829162 | 7.34 |
ENST00000291009.3
|
PIP
|
prolactin-induced protein |
chr22_-_38902300 | 7.33 |
ENST00000403230.1
|
DDX17
|
DEAD (Asp-Glu-Ala-Asp) box helicase 17 |
chr19_+_1041212 | 7.29 |
ENST00000433129.1
|
ABCA7
|
ATP-binding cassette, sub-family A (ABC1), member 7 |
chr2_+_163200848 | 7.28 |
ENST00000233612.4
|
GCA
|
grancalcin, EF-hand calcium binding protein |
chr12_+_32112340 | 7.14 |
ENST00000540924.1
ENST00000312561.4 |
KIAA1551
|
KIAA1551 |
chr11_-_10590238 | 7.08 |
ENST00000256178.3
|
LYVE1
|
lymphatic vessel endothelial hyaluronan receptor 1 |
chr6_-_32820529 | 7.08 |
ENST00000425148.2
|
TAP1
|
transporter 1, ATP-binding cassette, sub-family B (MDR/TAP) |
chr17_-_29641104 | 7.06 |
ENST00000577894.1
ENST00000330927.4 |
EVI2B
|
ecotropic viral integration site 2B |
chr14_-_25103388 | 7.05 |
ENST00000526004.1
ENST00000415355.3 |
GZMB
|
granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1) |
chr5_+_40909354 | 7.05 |
ENST00000313164.9
|
C7
|
complement component 7 |
chr2_+_90192768 | 7.00 |
ENST00000390275.2
|
IGKV1D-13
|
immunoglobulin kappa variable 1D-13 |
chr7_+_80275752 | 7.00 |
ENST00000419819.2
|
CD36
|
CD36 molecule (thrombospondin receptor) |
chr14_-_25103472 | 6.98 |
ENST00000216341.4
ENST00000382542.1 ENST00000382540.1 |
GZMB
|
granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1) |
chr19_+_54704610 | 6.80 |
ENST00000302907.4
|
RPS9
|
ribosomal protein S9 |
chr5_-_169725231 | 6.79 |
ENST00000046794.5
|
LCP2
|
lymphocyte cytosolic protein 2 (SH2 domain containing leukocyte protein of 76kDa) |
chr13_-_46964177 | 6.73 |
ENST00000389908.3
|
KIAA0226L
|
KIAA0226-like |
chr11_-_615570 | 6.61 |
ENST00000525445.1
ENST00000348655.6 ENST00000397566.1 |
IRF7
|
interferon regulatory factor 7 |
chr15_-_38856836 | 6.61 |
ENST00000450598.2
ENST00000559830.1 ENST00000558164.1 ENST00000310803.5 |
RASGRP1
|
RAS guanyl releasing protein 1 (calcium and DAG-regulated) |
chr1_-_161519579 | 6.60 |
ENST00000426740.1
|
FCGR3A
|
Fc fragment of IgG, low affinity IIIa, receptor (CD16a) |
chr16_-_21663919 | 6.56 |
ENST00000569602.1
|
IGSF6
|
immunoglobulin superfamily, member 6 |
chr1_+_158979792 | 6.47 |
ENST00000359709.3
ENST00000430894.2 |
IFI16
|
interferon, gamma-inducible protein 16 |
chr6_-_32634425 | 6.42 |
ENST00000399082.3
ENST00000399079.3 ENST00000374943.4 ENST00000434651.2 |
HLA-DQB1
|
major histocompatibility complex, class II, DQ beta 1 |
chr12_-_54689532 | 6.37 |
ENST00000540264.2
ENST00000312156.4 |
NFE2
|
nuclear factor, erythroid 2 |
chr7_+_117120017 | 6.34 |
ENST00000003084.6
ENST00000454343.1 |
CFTR
|
cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7) |
chr12_-_117537240 | 6.28 |
ENST00000392545.4
ENST00000541210.1 ENST00000335209.7 |
TESC
|
tescalcin |
chr5_-_172198190 | 6.22 |
ENST00000239223.3
|
DUSP1
|
dual specificity phosphatase 1 |
chr11_+_117049910 | 6.20 |
ENST00000431081.2
ENST00000524842.1 |
SIDT2
|
SID1 transmembrane family, member 2 |
chr1_-_161600822 | 6.17 |
ENST00000534776.1
ENST00000540048.1 |
FCGR3B
FCGR3A
|
Fc fragment of IgG, low affinity IIIb, receptor (CD16b) Fc fragment of IgG, low affinity IIIa, receptor (CD16a) |
chr11_+_128563652 | 6.16 |
ENST00000527786.2
|
FLI1
|
Fli-1 proto-oncogene, ETS transcription factor |
chr19_+_55128576 | 6.12 |
ENST00000396331.1
|
LILRB1
|
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 1 |
chr14_+_75988851 | 6.03 |
ENST00000555504.1
|
BATF
|
basic leucine zipper transcription factor, ATF-like |
chr14_+_61789382 | 5.98 |
ENST00000555082.1
|
PRKCH
|
protein kinase C, eta |
chr7_-_36764004 | 5.88 |
ENST00000431169.1
|
AOAH
|
acyloxyacyl hydrolase (neutrophil) |
chr3_+_38179969 | 5.87 |
ENST00000396334.3
ENST00000417037.2 ENST00000424893.1 ENST00000495303.1 ENST00000443433.2 ENST00000421516.1 |
MYD88
|
myeloid differentiation primary response 88 |
chr16_-_20338748 | 5.77 |
ENST00000575582.1
ENST00000341642.5 ENST00000381362.4 ENST00000572347.1 ENST00000572478.1 ENST00000302555.5 |
GP2
|
glycoprotein 2 (zymogen granule membrane) |
chr7_+_139529040 | 5.74 |
ENST00000455353.1
ENST00000458722.1 ENST00000411653.1 |
TBXAS1
|
thromboxane A synthase 1 (platelet) |
chr1_+_158979680 | 5.72 |
ENST00000368131.4
ENST00000340979.6 |
IFI16
|
interferon, gamma-inducible protein 16 |
chr22_-_24096562 | 5.71 |
ENST00000398465.3
|
VPREB3
|
pre-B lymphocyte 3 |
chr6_+_144471643 | 5.70 |
ENST00000367568.4
|
STX11
|
syntaxin 11 |
chr19_-_40023450 | 5.67 |
ENST00000326282.4
|
EID2B
|
EP300 interacting inhibitor of differentiation 2B |
chr17_+_77681075 | 5.63 |
ENST00000397549.2
|
CTD-2116F7.1
|
CTD-2116F7.1 |
chr22_-_38902325 | 5.62 |
ENST00000396821.3
ENST00000381633.3 |
DDX17
|
DEAD (Asp-Glu-Ala-Asp) box helicase 17 |
chr13_+_111767650 | 5.62 |
ENST00000449979.1
ENST00000370623.3 |
ARHGEF7
|
Rho guanine nucleotide exchange factor (GEF) 7 |
chr16_+_53468332 | 5.60 |
ENST00000262133.6
|
RBL2
|
retinoblastoma-like 2 (p130) |
chr20_-_43280361 | 5.58 |
ENST00000372874.4
|
ADA
|
adenosine deaminase |
chr1_-_161600990 | 5.58 |
ENST00000531221.1
|
FCGR3B
|
Fc fragment of IgG, low affinity IIIb, receptor (CD16b) |
chr19_-_40324767 | 5.47 |
ENST00000601972.1
ENST00000430012.2 ENST00000323039.5 ENST00000348817.3 |
DYRK1B
|
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1B |
chr19_+_55361898 | 5.45 |
ENST00000326321.3
ENST00000270442.5 |
KIR3DL2
|
killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2 |
chr1_+_158979686 | 5.44 |
ENST00000368132.3
ENST00000295809.7 |
IFI16
|
interferon, gamma-inducible protein 16 |
chr12_+_56324756 | 5.42 |
ENST00000331886.5
ENST00000555090.1 |
DGKA
|
diacylglycerol kinase, alpha 80kDa |
chr21_+_34602377 | 5.39 |
ENST00000342101.3
ENST00000413881.1 ENST00000443073.1 |
IFNAR2
|
interferon (alpha, beta and omega) receptor 2 |
chr1_-_161600942 | 5.38 |
ENST00000421702.2
|
FCGR3B
|
Fc fragment of IgG, low affinity IIIb, receptor (CD16b) |
chr19_-_59084647 | 5.32 |
ENST00000594234.1
ENST00000596039.1 |
MZF1
|
myeloid zinc finger 1 |
chr11_-_10590118 | 5.30 |
ENST00000529598.1
|
LYVE1
|
lymphatic vessel endothelial hyaluronan receptor 1 |
chr1_-_161519682 | 5.27 |
ENST00000367969.3
ENST00000443193.1 |
FCGR3A
|
Fc fragment of IgG, low affinity IIIa, receptor (CD16a) |
chr5_+_137225158 | 5.26 |
ENST00000290431.5
|
PKD2L2
|
polycystic kidney disease 2-like 2 |
chr10_-_6019552 | 5.21 |
ENST00000379977.3
ENST00000397251.3 ENST00000397248.2 |
IL15RA
|
interleukin 15 receptor, alpha |
chr17_-_80408569 | 5.20 |
ENST00000577696.1
ENST00000577471.1 ENST00000582545.2 ENST00000437807.2 ENST00000583617.1 ENST00000578913.1 ENST00000336995.7 ENST00000577834.1 ENST00000342572.8 ENST00000585064.1 ENST00000585080.1 ENST00000578919.1 ENST00000306645.5 ENST00000434650.2 |
C17orf62
|
chromosome 17 open reading frame 62 |
chr7_+_139528952 | 5.18 |
ENST00000416849.2
ENST00000436047.2 ENST00000414508.2 ENST00000448866.1 |
TBXAS1
|
thromboxane A synthase 1 (platelet) |
chr19_+_51728316 | 5.10 |
ENST00000436584.2
ENST00000421133.2 ENST00000391796.3 ENST00000262262.4 |
CD33
|
CD33 molecule |
chr13_-_33112956 | 5.06 |
ENST00000505213.1
|
N4BP2L2
|
NEDD4 binding protein 2-like 2 |
chr21_+_34602200 | 5.04 |
ENST00000382264.3
ENST00000382241.3 ENST00000404220.3 ENST00000342136.4 |
IFNAR2
|
interferon (alpha, beta and omega) receptor 2 |
chr15_+_58430567 | 5.03 |
ENST00000536493.1
|
AQP9
|
aquaporin 9 |
chr8_+_104427581 | 5.01 |
ENST00000521716.1
ENST00000521971.1 ENST00000519682.1 |
DCAF13
|
DDB1 and CUL4 associated factor 13 |
chr19_+_52264104 | 4.98 |
ENST00000340023.6
|
FPR2
|
formyl peptide receptor 2 |
chr6_-_39693111 | 4.97 |
ENST00000373215.3
ENST00000538893.1 ENST00000287152.7 ENST00000373216.3 |
KIF6
|
kinesin family member 6 |
chr6_-_137539651 | 4.97 |
ENST00000543628.1
|
IFNGR1
|
interferon gamma receptor 1 |
chr17_-_40021656 | 4.88 |
ENST00000319121.3
|
KLHL11
|
kelch-like family member 11 |
chr17_-_76124711 | 4.83 |
ENST00000306591.7
ENST00000590602.1 |
TMC6
|
transmembrane channel-like 6 |
chr15_-_64648273 | 4.83 |
ENST00000607537.1
ENST00000303052.7 ENST00000303032.6 |
CSNK1G1
|
casein kinase 1, gamma 1 |
chr17_-_27224621 | 4.82 |
ENST00000394906.2
ENST00000585169.1 ENST00000394908.4 |
FLOT2
|
flotillin 2 |
chr15_-_73076030 | 4.82 |
ENST00000311669.8
|
ADPGK
|
ADP-dependent glucokinase |
chr3_+_111260856 | 4.81 |
ENST00000352690.4
|
CD96
|
CD96 molecule |
chr5_-_180236811 | 4.80 |
ENST00000446023.2
|
MGAT1
|
mannosyl (alpha-1,3-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase |
chr12_-_56727487 | 4.77 |
ENST00000548043.1
ENST00000425394.2 |
PAN2
|
PAN2 poly(A) specific ribonuclease subunit homolog (S. cerevisiae) |
chrX_-_65253506 | 4.76 |
ENST00000427538.1
|
VSIG4
|
V-set and immunoglobulin domain containing 4 |
chr5_+_150400124 | 4.76 |
ENST00000388825.4
ENST00000521650.1 ENST00000517973.1 |
GPX3
|
glutathione peroxidase 3 (plasma) |
chr6_+_131894284 | 4.72 |
ENST00000368087.3
ENST00000356962.2 |
ARG1
|
arginase 1 |
chr1_-_25558984 | 4.72 |
ENST00000236273.4
|
SYF2
|
SYF2 pre-mRNA-splicing factor |
chr19_-_50529193 | 4.72 |
ENST00000596445.1
ENST00000599538.1 |
VRK3
|
vaccinia related kinase 3 |
chrY_+_22737604 | 4.72 |
ENST00000361365.2
|
EIF1AY
|
eukaryotic translation initiation factor 1A, Y-linked |
chr19_+_44617511 | 4.71 |
ENST00000262894.6
ENST00000588926.1 ENST00000592780.1 |
ZNF225
|
zinc finger protein 225 |
chr10_+_30722866 | 4.67 |
ENST00000263056.1
|
MAP3K8
|
mitogen-activated protein kinase kinase kinase 8 |
chr9_-_88356733 | 4.64 |
ENST00000376083.3
|
AGTPBP1
|
ATP/GTP binding protein 1 |
chr19_+_10197463 | 4.59 |
ENST00000590378.1
ENST00000397881.3 |
C19orf66
|
chromosome 19 open reading frame 66 |
chr4_+_128651530 | 4.58 |
ENST00000281154.4
|
SLC25A31
|
solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 31 |
chr16_-_21663950 | 4.58 |
ENST00000268389.4
|
IGSF6
|
immunoglobulin superfamily, member 6 |
chr14_+_95078714 | 4.57 |
ENST00000393078.3
ENST00000393080.4 ENST00000467132.1 |
SERPINA3
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 3 |
chr6_-_41703952 | 4.57 |
ENST00000358871.2
ENST00000403298.4 |
TFEB
|
transcription factor EB |
chr19_+_55327923 | 4.57 |
ENST00000391728.4
ENST00000326542.7 ENST00000358178.4 |
KIR3DL1
|
killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1 |
chr7_-_76829125 | 4.56 |
ENST00000248598.5
|
FGL2
|
fibrinogen-like 2 |
chrX_+_122993657 | 4.45 |
ENST00000434753.3
ENST00000430625.1 |
XIAP
|
X-linked inhibitor of apoptosis |
chr12_-_56727676 | 4.43 |
ENST00000547572.1
ENST00000257931.5 ENST00000440411.3 |
PAN2
|
PAN2 poly(A) specific ribonuclease subunit homolog (S. cerevisiae) |
chr10_-_72362515 | 4.42 |
ENST00000373209.2
ENST00000441259.1 |
PRF1
|
perforin 1 (pore forming protein) |
chr11_-_22851367 | 4.35 |
ENST00000354193.4
|
SVIP
|
small VCP/p97-interacting protein |
chr1_+_158325684 | 4.34 |
ENST00000368162.2
|
CD1E
|
CD1e molecule |
chr11_-_59383617 | 4.33 |
ENST00000263847.1
|
OSBP
|
oxysterol binding protein |
chr13_-_99959641 | 4.32 |
ENST00000376414.4
|
GPR183
|
G protein-coupled receptor 183 |
chr5_-_64777733 | 4.31 |
ENST00000381055.3
|
ADAMTS6
|
ADAM metallopeptidase with thrombospondin type 1 motif, 6 |
chr10_+_26727125 | 4.27 |
ENST00000376236.4
|
APBB1IP
|
amyloid beta (A4) precursor protein-binding, family B, member 1 interacting protein |
chr11_+_121461097 | 4.25 |
ENST00000527934.1
|
SORL1
|
sortilin-related receptor, L(DLR class) A repeats containing |
chr13_-_33112899 | 4.23 |
ENST00000267068.3
ENST00000357505.6 ENST00000399396.3 |
N4BP2L2
|
NEDD4 binding protein 2-like 2 |
chr16_+_27413483 | 4.22 |
ENST00000337929.3
ENST00000564089.1 |
IL21R
|
interleukin 21 receptor |
chr22_-_24096630 | 4.20 |
ENST00000248948.3
|
VPREB3
|
pre-B lymphocyte 3 |
chr6_+_35995552 | 4.17 |
ENST00000468133.1
|
MAPK14
|
mitogen-activated protein kinase 14 |
chr22_+_22936998 | 4.16 |
ENST00000390303.2
|
IGLV3-32
|
immunoglobulin lambda variable 3-32 (non-functional) |
chr4_+_87856129 | 4.15 |
ENST00000395146.4
ENST00000507468.1 |
AFF1
|
AF4/FMR2 family, member 1 |
chr16_-_1661988 | 4.14 |
ENST00000426508.2
|
IFT140
|
intraflagellar transport 140 homolog (Chlamydomonas) |
chr3_+_101443476 | 4.14 |
ENST00000327230.4
ENST00000494050.1 |
CEP97
|
centrosomal protein 97kDa |
chr4_-_38806404 | 4.12 |
ENST00000308979.2
ENST00000505940.1 ENST00000515861.1 |
TLR1
|
toll-like receptor 1 |
chr20_+_16729003 | 4.12 |
ENST00000246081.2
|
OTOR
|
otoraplin |
chr9_-_88356789 | 4.10 |
ENST00000357081.3
ENST00000376081.4 ENST00000337006.4 ENST00000376109.3 |
AGTPBP1
|
ATP/GTP binding protein 1 |
chr19_+_54705025 | 4.10 |
ENST00000441429.1
|
RPS9
|
ribosomal protein S9 |
chr15_-_86338134 | 4.10 |
ENST00000337975.5
|
KLHL25
|
kelch-like family member 25 |
chr17_+_75123947 | 4.08 |
ENST00000586429.1
|
SEC14L1
|
SEC14-like 1 (S. cerevisiae) |
chr12_+_56324933 | 4.08 |
ENST00000549629.1
ENST00000555218.1 |
DGKA
|
diacylglycerol kinase, alpha 80kDa |
chr1_+_36690011 | 4.07 |
ENST00000354618.5
ENST00000469141.2 ENST00000478853.1 |
THRAP3
|
thyroid hormone receptor associated protein 3 |
chr8_+_95565947 | 4.07 |
ENST00000523011.1
|
RP11-267M23.4
|
RP11-267M23.4 |
chr13_-_45915221 | 4.07 |
ENST00000309246.5
ENST00000379060.4 ENST00000379055.1 ENST00000527226.1 ENST00000379056.1 |
TPT1
|
tumor protein, translationally-controlled 1 |
chr4_+_15779901 | 4.06 |
ENST00000226279.3
|
CD38
|
CD38 molecule |
chr5_+_137225125 | 4.05 |
ENST00000350250.4
ENST00000508638.1 ENST00000502810.1 ENST00000508883.1 |
PKD2L2
|
polycystic kidney disease 2-like 2 |
chr16_+_67198683 | 4.04 |
ENST00000517685.1
ENST00000521374.1 ENST00000584272.1 |
HSF4
|
heat shock transcription factor 4 |
chr1_+_12123414 | 4.04 |
ENST00000263932.2
|
TNFRSF8
|
tumor necrosis factor receptor superfamily, member 8 |
chr12_+_93964746 | 4.04 |
ENST00000536696.2
|
SOCS2
|
suppressor of cytokine signaling 2 |
chr19_+_55281260 | 4.03 |
ENST00000336077.6
ENST00000291633.7 |
KIR2DL1
|
killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 1 |
chr8_-_56685966 | 3.99 |
ENST00000334667.2
|
TMEM68
|
transmembrane protein 68 |
chr1_+_149754227 | 3.98 |
ENST00000444948.1
ENST00000369168.4 |
FCGR1A
|
Fc fragment of IgG, high affinity Ia, receptor (CD64) |
chr7_+_117120106 | 3.96 |
ENST00000426809.1
|
CFTR
|
cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7) |
chr6_+_20534672 | 3.94 |
ENST00000274695.4
ENST00000378624.4 |
CDKAL1
|
CDK5 regulatory subunit associated protein 1-like 1 |
chr9_-_89562104 | 3.94 |
ENST00000298743.7
|
GAS1
|
growth arrest-specific 1 |
chr8_+_27168988 | 3.94 |
ENST00000397501.1
ENST00000338238.4 ENST00000544172.1 |
PTK2B
|
protein tyrosine kinase 2 beta |
chrY_+_22737678 | 3.94 |
ENST00000382772.3
|
EIF1AY
|
eukaryotic translation initiation factor 1A, Y-linked |
chr4_-_40517984 | 3.94 |
ENST00000381795.6
|
RBM47
|
RNA binding motif protein 47 |
chrX_+_15767971 | 3.93 |
ENST00000479740.1
ENST00000454127.2 |
CA5B
|
carbonic anhydrase VB, mitochondrial |
chr15_-_75660919 | 3.91 |
ENST00000569482.1
ENST00000565683.1 ENST00000561615.1 ENST00000563622.1 ENST00000568374.1 ENST00000566256.1 ENST00000267978.5 |
MAN2C1
|
mannosidase, alpha, class 2C, member 1 |
chr4_-_185395672 | 3.90 |
ENST00000393593.3
|
IRF2
|
interferon regulatory factor 2 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
11.6 | 46.4 | GO:0071461 | cellular response to redox state(GO:0071461) |
5.5 | 16.4 | GO:0002727 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
5.4 | 16.2 | GO:0071140 | resolution of recombination intermediates(GO:0071139) resolution of mitotic recombination intermediates(GO:0071140) |
4.5 | 17.9 | GO:0071725 | toll-like receptor TLR1:TLR2 signaling pathway(GO:0038123) response to triacyl bacterial lipopeptide(GO:0071725) cellular response to triacyl bacterial lipopeptide(GO:0071727) |
4.2 | 16.8 | GO:0005986 | sucrose biosynthetic process(GO:0005986) |
4.2 | 16.6 | GO:0002503 | peptide antigen assembly with MHC class II protein complex(GO:0002503) |
3.9 | 19.3 | GO:0014738 | regulation of muscle hyperplasia(GO:0014738) |
3.9 | 19.3 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
3.6 | 18.1 | GO:2000110 | negative regulation of macrophage apoptotic process(GO:2000110) |
3.4 | 10.3 | GO:1902161 | positive regulation of cyclic nucleotide-gated ion channel activity(GO:1902161) |
3.1 | 9.3 | GO:0046102 | hypoxanthine salvage(GO:0043103) inosine metabolic process(GO:0046102) |
2.9 | 8.7 | GO:0035610 | protein side chain deglutamylation(GO:0035610) |
2.9 | 17.4 | GO:0045903 | positive regulation of translational fidelity(GO:0045903) |
2.7 | 8.2 | GO:0035915 | pore formation in membrane of other organism(GO:0035915) |
2.6 | 15.4 | GO:0071724 | toll-like receptor TLR6:TLR2 signaling pathway(GO:0038124) response to diacyl bacterial lipopeptide(GO:0071724) cellular response to diacyl bacterial lipopeptide(GO:0071726) |
2.5 | 20.0 | GO:0044351 | macropinocytosis(GO:0044351) |
2.4 | 7.3 | GO:1902994 | regulation of phospholipid efflux(GO:1902994) positive regulation of phospholipid efflux(GO:1902995) |
2.3 | 9.1 | GO:0000255 | allantoin metabolic process(GO:0000255) |
2.3 | 11.4 | GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
2.1 | 12.8 | GO:0070269 | pyroptosis(GO:0070269) |
2.1 | 8.4 | GO:0035712 | T-helper 2 cell activation(GO:0035712) regulation of T-helper 2 cell activation(GO:2000569) positive regulation of T-helper 2 cell activation(GO:2000570) |
2.1 | 6.2 | GO:0044278 | cell wall disruption in other organism(GO:0044278) |
2.0 | 6.1 | GO:1903595 | positive regulation of histamine secretion by mast cell(GO:1903595) |
2.0 | 6.1 | GO:0090290 | positive regulation of osteoclast proliferation(GO:0090290) |
2.0 | 14.0 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
2.0 | 2.0 | GO:0006544 | glycine metabolic process(GO:0006544) |
1.8 | 7.4 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
1.8 | 7.1 | GO:0046967 | cytosol to ER transport(GO:0046967) |
1.8 | 10.6 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
1.6 | 4.8 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
1.5 | 6.1 | GO:2001193 | gamma-delta T cell activation involved in immune response(GO:0002290) negative regulation of interferon-beta secretion(GO:0035548) regulation of gamma-delta T cell activation involved in immune response(GO:2001191) positive regulation of gamma-delta T cell activation involved in immune response(GO:2001193) |
1.5 | 4.4 | GO:1902530 | regulation of protein linear polyubiquitination(GO:1902528) positive regulation of protein linear polyubiquitination(GO:1902530) |
1.5 | 4.4 | GO:0042700 | luteinizing hormone signaling pathway(GO:0042700) |
1.5 | 4.4 | GO:1903070 | negative regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903070) |
1.4 | 10.1 | GO:0010749 | regulation of nitric oxide mediated signal transduction(GO:0010749) |
1.4 | 4.3 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
1.4 | 10.0 | GO:1902035 | positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
1.4 | 4.2 | GO:1905246 | regulation of choline O-acetyltransferase activity(GO:1902769) positive regulation of choline O-acetyltransferase activity(GO:1902771) negative regulation of tau-protein kinase activity(GO:1902948) positive regulation of early endosome to recycling endosome transport(GO:1902955) negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902960) negative regulation of neurofibrillary tangle assembly(GO:1902997) negative regulation of aspartic-type peptidase activity(GO:1905246) |
1.4 | 15.1 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) |
1.3 | 4.0 | GO:0032679 | TRAIL production(GO:0032639) regulation of TRAIL production(GO:0032679) positive regulation of TRAIL production(GO:0032759) |
1.3 | 3.9 | GO:0010752 | regulation of cGMP-mediated signaling(GO:0010752) |
1.3 | 3.9 | GO:0060168 | positive regulation of adenosine receptor signaling pathway(GO:0060168) |
1.3 | 28.2 | GO:0097186 | amelogenesis(GO:0097186) |
1.3 | 3.8 | GO:1903413 | cellular response to bile acid(GO:1903413) negative regulation of intestinal absorption(GO:1904479) response to iron ion starvation(GO:1990641) |
1.2 | 6.1 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
1.2 | 3.6 | GO:1904425 | negative regulation of GTP binding(GO:1904425) |
1.2 | 4.8 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
1.2 | 5.9 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
1.1 | 3.4 | GO:1904604 | regulation of connective tissue replacement involved in inflammatory response wound healing(GO:1904596) negative regulation of connective tissue replacement involved in inflammatory response wound healing(GO:1904597) regulation of advanced glycation end-product receptor activity(GO:1904603) negative regulation of advanced glycation end-product receptor activity(GO:1904604) negative regulation of connective tissue replacement(GO:1905204) |
1.1 | 6.6 | GO:0032252 | secretory granule localization(GO:0032252) |
1.1 | 3.3 | GO:0002731 | negative regulation of dendritic cell cytokine production(GO:0002731) |
1.1 | 3.3 | GO:0038178 | complement component C5a signaling pathway(GO:0038178) negative regulation of granulocyte chemotaxis(GO:0071623) negative regulation of neutrophil chemotaxis(GO:0090024) negative regulation of neutrophil migration(GO:1902623) |
1.1 | 2.2 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
1.1 | 12.7 | GO:0030202 | heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
1.1 | 3.2 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
1.0 | 3.1 | GO:0045062 | extrathymic T cell selection(GO:0045062) |
1.0 | 6.1 | GO:1903903 | regulation of establishment of T cell polarity(GO:1903903) |
1.0 | 4.0 | GO:0002767 | immune response-inhibiting signal transduction(GO:0002765) immune response-inhibiting cell surface receptor signaling pathway(GO:0002767) |
1.0 | 3.0 | GO:0097254 | renal tubular secretion(GO:0097254) |
1.0 | 8.9 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
1.0 | 2.0 | GO:2000977 | regulation of forebrain neuron differentiation(GO:2000977) |
0.9 | 4.7 | GO:1902023 | L-arginine import(GO:0043091) arginine import(GO:0090467) L-arginine transport(GO:1902023) |
0.9 | 2.8 | GO:0048250 | mitochondrial iron ion transport(GO:0048250) |
0.9 | 1.8 | GO:0002032 | desensitization of G-protein coupled receptor protein signaling pathway by arrestin(GO:0002032) |
0.9 | 3.5 | GO:0001970 | positive regulation of activation of membrane attack complex(GO:0001970) |
0.9 | 6.2 | GO:0033227 | dsRNA transport(GO:0033227) |
0.9 | 2.6 | GO:0002125 | maternal aggressive behavior(GO:0002125) positive regulation of female receptivity(GO:0045925) |
0.9 | 2.6 | GO:1990637 | response to prolactin(GO:1990637) |
0.9 | 3.5 | GO:0003335 | corneocyte development(GO:0003335) |
0.8 | 6.6 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.8 | 5.6 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.8 | 5.6 | GO:0008218 | bioluminescence(GO:0008218) |
0.8 | 19.0 | GO:0045730 | respiratory burst(GO:0045730) |
0.8 | 3.2 | GO:0036337 | Fas signaling pathway(GO:0036337) |
0.8 | 2.3 | GO:0050883 | musculoskeletal movement, spinal reflex action(GO:0050883) |
0.8 | 7.7 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.8 | 2.3 | GO:0000354 | cis assembly of pre-catalytic spliceosome(GO:0000354) |
0.8 | 3.0 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
0.7 | 6.0 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.7 | 2.2 | GO:0060474 | positive regulation of sperm motility involved in capacitation(GO:0060474) |
0.7 | 2.2 | GO:0010430 | fatty acid omega-oxidation(GO:0010430) |
0.7 | 6.6 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.7 | 2.2 | GO:0019556 | histidine catabolic process to glutamate and formamide(GO:0019556) histidine catabolic process to glutamate and formate(GO:0019557) formamide metabolic process(GO:0043606) |
0.7 | 1.4 | GO:0002436 | immune complex clearance(GO:0002434) immune complex clearance by monocytes and macrophages(GO:0002436) regulation of immune complex clearance by monocytes and macrophages(GO:0090264) |
0.7 | 29.9 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
0.7 | 3.5 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
0.7 | 13.4 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
0.7 | 2.1 | GO:0048485 | sympathetic nervous system development(GO:0048485) |
0.7 | 11.7 | GO:1901741 | positive regulation of myoblast fusion(GO:1901741) |
0.7 | 2.1 | GO:0070171 | negative regulation of tooth mineralization(GO:0070171) |
0.7 | 2.1 | GO:0006710 | androgen catabolic process(GO:0006710) |
0.7 | 2.7 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.7 | 17.0 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.7 | 2.0 | GO:0046968 | peptide antigen transport(GO:0046968) |
0.7 | 25.6 | GO:1900077 | negative regulation of cellular response to insulin stimulus(GO:1900077) |
0.7 | 2.0 | GO:0030241 | skeletal muscle myosin thick filament assembly(GO:0030241) |
0.6 | 2.6 | GO:0036015 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
0.6 | 84.0 | GO:0060333 | interferon-gamma-mediated signaling pathway(GO:0060333) |
0.6 | 1.3 | GO:0002874 | regulation of chronic inflammatory response to antigenic stimulus(GO:0002874) |
0.6 | 11.8 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.6 | 4.3 | GO:0044126 | regulation of growth of symbiont in host(GO:0044126) |
0.6 | 3.7 | GO:0070945 | neutrophil mediated killing of gram-negative bacterium(GO:0070945) |
0.6 | 10.9 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
0.6 | 3.0 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
0.6 | 5.3 | GO:0086024 | adrenergic receptor signaling pathway involved in positive regulation of heart rate(GO:0086024) |
0.6 | 2.3 | GO:0042713 | sperm ejaculation(GO:0042713) |
0.6 | 12.9 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
0.6 | 8.0 | GO:0032516 | positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
0.6 | 1.7 | GO:0003099 | regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback(GO:0001978) baroreceptor response to increased systemic arterial blood pressure(GO:0001983) positive regulation of the force of heart contraction by chemical signal(GO:0003099) |
0.6 | 4.5 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
0.6 | 2.8 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.6 | 5.0 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.5 | 3.2 | GO:0090116 | C-5 methylation of cytosine(GO:0090116) |
0.5 | 1.1 | GO:0002329 | pre-B cell differentiation(GO:0002329) pre-B cell allelic exclusion(GO:0002331) |
0.5 | 2.7 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.5 | 5.3 | GO:0045779 | negative regulation of bone resorption(GO:0045779) |
0.5 | 1.6 | GO:1901052 | sarcosine metabolic process(GO:1901052) sarcosine catabolic process(GO:1901053) |
0.5 | 2.1 | GO:2000553 | positive regulation of T-helper 2 cell cytokine production(GO:2000553) |
0.5 | 1.6 | GO:0043461 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.5 | 1.6 | GO:0060672 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.5 | 3.6 | GO:0075044 | autophagy of host cells involved in interaction with symbiont(GO:0075044) autophagy involved in symbiotic interaction(GO:0075071) |
0.5 | 1.0 | GO:0006924 | activation-induced cell death of T cells(GO:0006924) |
0.5 | 3.6 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
0.5 | 2.6 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.5 | 2.0 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
0.5 | 2.5 | GO:0014005 | microglia differentiation(GO:0014004) microglia development(GO:0014005) |
0.5 | 5.4 | GO:0002418 | immune response to tumor cell(GO:0002418) |
0.5 | 1.5 | GO:1903926 | signal transduction involved in intra-S DNA damage checkpoint(GO:0072428) response to bisphenol A(GO:1903925) cellular response to bisphenol A(GO:1903926) |
0.5 | 85.9 | GO:0002433 | immune response-regulating cell surface receptor signaling pathway involved in phagocytosis(GO:0002433) Fc-gamma receptor signaling pathway involved in phagocytosis(GO:0038096) |
0.5 | 3.9 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.5 | 1.5 | GO:0035378 | carbon dioxide transmembrane transport(GO:0035378) |
0.5 | 1.5 | GO:0006014 | D-ribose metabolic process(GO:0006014) |
0.5 | 1.9 | GO:0097210 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.5 | 1.9 | GO:0097089 | methyl-branched fatty acid metabolic process(GO:0097089) |
0.5 | 1.9 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.5 | 11.2 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.5 | 1.9 | GO:0043932 | ossification involved in bone remodeling(GO:0043932) |
0.5 | 2.3 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
0.5 | 4.1 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.4 | 9.9 | GO:0030214 | hyaluronan catabolic process(GO:0030214) |
0.4 | 3.6 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
0.4 | 1.8 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.4 | 6.0 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.4 | 1.7 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
0.4 | 2.6 | GO:1900165 | negative regulation of interleukin-6 secretion(GO:1900165) |
0.4 | 1.3 | GO:0061534 | gamma-aminobutyric acid secretion, neurotransmission(GO:0061534) |
0.4 | 6.0 | GO:0099517 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
0.4 | 3.8 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.4 | 2.1 | GO:0016998 | cell wall macromolecule catabolic process(GO:0016998) |
0.4 | 6.2 | GO:1903504 | peptidyl-threonine dephosphorylation(GO:0035970) regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) regulation of mitotic spindle checkpoint(GO:1903504) |
0.4 | 4.1 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.4 | 4.9 | GO:0002475 | antigen processing and presentation via MHC class Ib(GO:0002475) antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.4 | 2.4 | GO:0052203 | modulation by symbiont of host molecular function(GO:0052055) modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
0.4 | 1.2 | GO:0002361 | CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
0.4 | 11.1 | GO:0007520 | myoblast fusion(GO:0007520) |
0.4 | 3.2 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.4 | 0.8 | GO:0046110 | xanthine metabolic process(GO:0046110) |
0.4 | 1.9 | GO:0033216 | ferric iron import(GO:0033216) ferric iron import into cell(GO:0097461) ferric iron import across plasma membrane(GO:0098706) |
0.4 | 6.2 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.4 | 4.1 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.4 | 1.1 | GO:0019418 | sulfide oxidation(GO:0019418) sulfide oxidation, using sulfide:quinone oxidoreductase(GO:0070221) |
0.4 | 3.0 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
0.4 | 3.0 | GO:0007288 | acrosome assembly(GO:0001675) sperm axoneme assembly(GO:0007288) |
0.4 | 8.1 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
0.4 | 17.0 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.4 | 2.1 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
0.4 | 1.8 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
0.4 | 1.4 | GO:1902202 | regulation of endothelial tube morphogenesis(GO:1901509) regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
0.4 | 2.5 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.3 | 1.0 | GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
0.3 | 6.1 | GO:0070233 | negative regulation of T cell apoptotic process(GO:0070233) |
0.3 | 2.0 | GO:0006207 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) response to oleic acid(GO:0034201) |
0.3 | 1.3 | GO:0071321 | cellular response to cGMP(GO:0071321) |
0.3 | 2.9 | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
0.3 | 1.0 | GO:0001544 | initiation of primordial ovarian follicle growth(GO:0001544) |
0.3 | 4.1 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
0.3 | 1.9 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.3 | 19.5 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
0.3 | 2.7 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.3 | 8.2 | GO:0019731 | antibacterial humoral response(GO:0019731) |
0.3 | 5.7 | GO:0031629 | synaptic vesicle fusion to presynaptic active zone membrane(GO:0031629) vesicle fusion to plasma membrane(GO:0099500) |
0.3 | 1.1 | GO:0045591 | positive regulation of regulatory T cell differentiation(GO:0045591) |
0.3 | 0.6 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.3 | 2.5 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
0.3 | 1.7 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
0.3 | 8.6 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.3 | 1.1 | GO:0014724 | regulation of twitch skeletal muscle contraction(GO:0014724) |
0.3 | 0.5 | GO:0071109 | superior temporal gyrus development(GO:0071109) |
0.3 | 5.0 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.3 | 1.8 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.3 | 1.8 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.3 | 1.5 | GO:0060235 | embryonic retina morphogenesis in camera-type eye(GO:0060059) lens induction in camera-type eye(GO:0060235) |
0.3 | 1.5 | GO:0019530 | taurine metabolic process(GO:0019530) |
0.3 | 9.3 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
0.2 | 1.5 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.2 | 3.2 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.2 | 2.0 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
0.2 | 3.5 | GO:1902894 | negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
0.2 | 6.4 | GO:0006337 | nucleosome disassembly(GO:0006337) |
0.2 | 4.1 | GO:0001502 | cartilage condensation(GO:0001502) |
0.2 | 2.6 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
0.2 | 1.4 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.2 | 1.8 | GO:1901475 | pyruvate transport(GO:0006848) pyruvate transmembrane transport(GO:1901475) |
0.2 | 2.5 | GO:0042355 | fucose catabolic process(GO:0019317) L-fucose metabolic process(GO:0042354) L-fucose catabolic process(GO:0042355) |
0.2 | 3.2 | GO:0051546 | keratinocyte migration(GO:0051546) |
0.2 | 4.1 | GO:1902230 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902230) |
0.2 | 0.7 | GO:0048852 | hypophysis morphogenesis(GO:0048850) diencephalon morphogenesis(GO:0048852) |
0.2 | 2.0 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.2 | 2.7 | GO:0070307 | lens fiber cell development(GO:0070307) |
0.2 | 7.3 | GO:0050982 | detection of mechanical stimulus(GO:0050982) |
0.2 | 1.8 | GO:0007598 | blood coagulation, extrinsic pathway(GO:0007598) |
0.2 | 2.9 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
0.2 | 7.7 | GO:0042267 | natural killer cell mediated cytotoxicity(GO:0042267) |
0.2 | 13.3 | GO:0045576 | mast cell activation(GO:0045576) |
0.2 | 2.6 | GO:0000768 | syncytium formation by plasma membrane fusion(GO:0000768) |
0.2 | 1.1 | GO:0015747 | urate transport(GO:0015747) |
0.2 | 3.4 | GO:0048266 | behavioral response to pain(GO:0048266) |
0.2 | 1.7 | GO:1904293 | negative regulation of ERAD pathway(GO:1904293) |
0.2 | 0.8 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
0.2 | 3.1 | GO:0034162 | toll-like receptor 9 signaling pathway(GO:0034162) |
0.2 | 4.0 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.2 | 1.7 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.2 | 0.8 | GO:1903012 | positive regulation of bone development(GO:1903012) positive regulation of osteoclast development(GO:2001206) |
0.2 | 4.1 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.2 | 1.1 | GO:0060029 | convergent extension involved in organogenesis(GO:0060029) |
0.2 | 2.2 | GO:0098719 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.2 | 1.1 | GO:1904381 | Golgi apparatus mannose trimming(GO:1904381) |
0.2 | 1.8 | GO:0006265 | DNA topological change(GO:0006265) |
0.2 | 1.8 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.2 | 1.4 | GO:1902412 | regulation of mitotic cytokinesis(GO:1902412) |
0.2 | 0.5 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.2 | 8.2 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.2 | 1.0 | GO:0035655 | interleukin-18-mediated signaling pathway(GO:0035655) cellular response to interleukin-18(GO:0071351) |
0.2 | 0.5 | GO:0042938 | dipeptide transport(GO:0042938) |
0.2 | 3.7 | GO:0032878 | regulation of establishment or maintenance of cell polarity(GO:0032878) |
0.2 | 2.1 | GO:0036148 | phosphatidylglycerol acyl-chain remodeling(GO:0036148) |
0.2 | 0.8 | GO:0038044 | transforming growth factor-beta secretion(GO:0038044) |
0.2 | 1.7 | GO:0060632 | regulation of microtubule-based movement(GO:0060632) |
0.2 | 3.0 | GO:0019835 | cytolysis(GO:0019835) |
0.2 | 2.3 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
0.2 | 0.3 | GO:0016240 | autophagosome docking(GO:0016240) |
0.2 | 4.2 | GO:0042753 | positive regulation of circadian rhythm(GO:0042753) |
0.2 | 0.5 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
0.2 | 3.2 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.2 | 1.4 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.1 | 1.9 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.1 | 2.4 | GO:0032233 | positive regulation of actin filament bundle assembly(GO:0032233) |
0.1 | 1.6 | GO:0042904 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.1 | 4.6 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.1 | 1.4 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
0.1 | 0.8 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.1 | 8.4 | GO:0031295 | T cell costimulation(GO:0031295) |
0.1 | 0.3 | GO:0000965 | mitochondrial RNA 3'-end processing(GO:0000965) |
0.1 | 1.1 | GO:0015705 | iodide transport(GO:0015705) |
0.1 | 5.0 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.1 | 7.3 | GO:0006968 | cellular defense response(GO:0006968) |
0.1 | 4.7 | GO:0006953 | acute-phase response(GO:0006953) |
0.1 | 0.4 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.1 | 0.5 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
0.1 | 1.5 | GO:0048484 | enteric nervous system development(GO:0048484) |
0.1 | 1.5 | GO:0007512 | adult heart development(GO:0007512) |
0.1 | 1.4 | GO:0000187 | activation of MAPK activity(GO:0000187) |
0.1 | 1.1 | GO:0010898 | positive regulation of triglyceride catabolic process(GO:0010898) |
0.1 | 14.4 | GO:0002377 | immunoglobulin production(GO:0002377) |
0.1 | 4.8 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.1 | 5.7 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.1 | 4.3 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
0.1 | 1.5 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.1 | 1.0 | GO:0060012 | synaptic transmission, glycinergic(GO:0060012) |
0.1 | 1.9 | GO:0010447 | response to acidic pH(GO:0010447) |
0.1 | 5.7 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.1 | 2.7 | GO:0045332 | lipid translocation(GO:0034204) phospholipid translocation(GO:0045332) |
0.1 | 1.3 | GO:0032620 | interleukin-17 production(GO:0032620) |
0.1 | 0.9 | GO:1903799 | antral ovarian follicle growth(GO:0001547) vagina development(GO:0060068) epithelial cell proliferation involved in mammary gland duct elongation(GO:0060750) branch elongation involved in mammary gland duct branching(GO:0060751) negative regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903799) |
0.1 | 0.5 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.1 | 0.8 | GO:0021840 | directional guidance of interneurons involved in migration from the subpallium to the cortex(GO:0021840) chemorepulsion involved in interneuron migration from the subpallium to the cortex(GO:0021842) |
0.1 | 0.4 | GO:0072143 | renal interstitial fibroblast development(GO:0072141) mesangial cell development(GO:0072143) glomerular mesangial cell development(GO:0072144) |
0.1 | 3.6 | GO:0030101 | natural killer cell activation(GO:0030101) |
0.1 | 1.2 | GO:0010801 | negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
0.1 | 0.7 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
0.1 | 1.4 | GO:0006086 | acetyl-CoA biosynthetic process from pyruvate(GO:0006086) regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
0.1 | 1.4 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
0.1 | 1.2 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.1 | 1.0 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.1 | 1.4 | GO:0051895 | negative regulation of focal adhesion assembly(GO:0051895) |
0.1 | 1.2 | GO:0050832 | defense response to fungus(GO:0050832) |
0.1 | 4.3 | GO:0007040 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.1 | 1.8 | GO:0042423 | catechol-containing compound biosynthetic process(GO:0009713) catecholamine biosynthetic process(GO:0042423) |
0.1 | 1.1 | GO:1901750 | leukotriene D4 metabolic process(GO:1901748) leukotriene D4 biosynthetic process(GO:1901750) |
0.1 | 1.9 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.1 | 3.6 | GO:0046849 | bone remodeling(GO:0046849) |
0.1 | 1.0 | GO:0070831 | basement membrane assembly(GO:0070831) |
0.1 | 3.9 | GO:0034724 | DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
0.1 | 3.1 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.1 | 2.2 | GO:0046688 | response to copper ion(GO:0046688) |
0.1 | 3.3 | GO:0018146 | keratan sulfate biosynthetic process(GO:0018146) |
0.1 | 0.6 | GO:1903358 | regulation of Golgi organization(GO:1903358) |
0.1 | 0.6 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
0.1 | 0.2 | GO:0022614 | membrane to membrane docking(GO:0022614) |
0.1 | 0.9 | GO:0045475 | locomotor rhythm(GO:0045475) |
0.1 | 0.5 | GO:0060452 | positive regulation of cardiac muscle contraction(GO:0060452) |
0.1 | 1.2 | GO:0045807 | positive regulation of endocytosis(GO:0045807) |
0.1 | 1.1 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
0.1 | 0.8 | GO:0047484 | regulation of response to osmotic stress(GO:0047484) |
0.1 | 4.9 | GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) signal transduction involved in mitotic cell cycle checkpoint(GO:0072413) signal transduction involved in mitotic G1 DNA damage checkpoint(GO:0072431) intracellular signal transduction involved in G1 DNA damage checkpoint(GO:1902400) signal transduction involved in mitotic DNA damage checkpoint(GO:1902402) signal transduction involved in mitotic DNA integrity checkpoint(GO:1902403) |
0.1 | 1.0 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
0.1 | 3.3 | GO:1901385 | regulation of voltage-gated calcium channel activity(GO:1901385) |
0.1 | 2.6 | GO:0034332 | adherens junction organization(GO:0034332) |
0.1 | 2.5 | GO:0022400 | regulation of rhodopsin mediated signaling pathway(GO:0022400) |
0.1 | 0.3 | GO:1900154 | regulation of bone trabecula formation(GO:1900154) negative regulation of bone trabecula formation(GO:1900155) |
0.1 | 1.8 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.1 | 0.4 | GO:0002027 | regulation of heart rate(GO:0002027) |
0.1 | 0.9 | GO:0009299 | mRNA transcription(GO:0009299) |
0.1 | 1.1 | GO:0060349 | bone morphogenesis(GO:0060349) |
0.1 | 0.7 | GO:0038003 | opioid receptor signaling pathway(GO:0038003) |
0.1 | 1.4 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.1 | 1.6 | GO:0007194 | negative regulation of adenylate cyclase activity(GO:0007194) |
0.1 | 1.6 | GO:0071353 | cellular response to interleukin-4(GO:0071353) |
0.1 | 0.4 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
0.1 | 1.1 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
0.1 | 1.1 | GO:0002088 | lens development in camera-type eye(GO:0002088) |
0.1 | 1.3 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.1 | 1.9 | GO:0036075 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
0.1 | 1.8 | GO:0006612 | protein targeting to membrane(GO:0006612) |
0.1 | 0.8 | GO:0017145 | stem cell division(GO:0017145) |
0.1 | 0.2 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.1 | 0.3 | GO:0009048 | dosage compensation by inactivation of X chromosome(GO:0009048) |
0.1 | 1.7 | GO:2001022 | positive regulation of response to DNA damage stimulus(GO:2001022) |
0.1 | 1.4 | GO:0031214 | biomineral tissue development(GO:0031214) |
0.0 | 2.2 | GO:0010107 | potassium ion import(GO:0010107) |
0.0 | 0.6 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.0 | 0.8 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
0.0 | 0.2 | GO:0044791 | modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
0.0 | 0.8 | GO:0044030 | regulation of DNA methylation(GO:0044030) |
0.0 | 2.3 | GO:0007585 | respiratory gaseous exchange(GO:0007585) |
0.0 | 0.3 | GO:0034505 | tooth mineralization(GO:0034505) |
0.0 | 0.5 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.0 | 4.0 | GO:0006954 | inflammatory response(GO:0006954) |
0.0 | 1.2 | GO:0019433 | triglyceride catabolic process(GO:0019433) |
0.0 | 1.1 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.0 | 2.5 | GO:0006998 | nuclear envelope organization(GO:0006998) |
0.0 | 1.2 | GO:0016266 | O-glycan processing(GO:0016266) |
0.0 | 0.3 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.0 | 4.5 | GO:0002250 | adaptive immune response(GO:0002250) |
0.0 | 0.2 | GO:0043552 | positive regulation of phosphatidylinositol 3-kinase activity(GO:0043552) |
0.0 | 0.9 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.0 | 1.0 | GO:0060147 | regulation of posttranscriptional gene silencing(GO:0060147) regulation of gene silencing by miRNA(GO:0060964) regulation of gene silencing by RNA(GO:0060966) |
0.0 | 0.6 | GO:0060325 | face morphogenesis(GO:0060325) |
0.0 | 4.6 | GO:0030509 | BMP signaling pathway(GO:0030509) |
0.0 | 0.7 | GO:0030728 | ovulation(GO:0030728) |
0.0 | 0.7 | GO:0097178 | ruffle assembly(GO:0097178) |
0.0 | 1.0 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
0.0 | 0.3 | GO:0001570 | vasculogenesis(GO:0001570) |
0.0 | 0.5 | GO:0071354 | cellular response to interleukin-6(GO:0071354) |
0.0 | 0.7 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.0 | 0.9 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.0 | 0.7 | GO:0046426 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.0 | 0.7 | GO:0055010 | ventricular cardiac muscle tissue morphogenesis(GO:0055010) |
0.0 | 2.3 | GO:0070268 | cornification(GO:0070268) |
0.0 | 0.1 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.0 | 1.0 | GO:0010951 | negative regulation of endopeptidase activity(GO:0010951) |
0.0 | 0.5 | GO:2000249 | regulation of actin cytoskeleton reorganization(GO:2000249) |
0.0 | 0.1 | GO:0001507 | acetylcholine catabolic process in synaptic cleft(GO:0001507) acetylcholine catabolic process(GO:0006581) |
0.0 | 1.3 | GO:0032091 | negative regulation of protein binding(GO:0032091) |
0.0 | 0.9 | GO:0006378 | mRNA polyadenylation(GO:0006378) |
0.0 | 0.3 | GO:0006825 | copper ion transport(GO:0006825) |
0.0 | 0.6 | GO:0007265 | Ras protein signal transduction(GO:0007265) |
0.0 | 0.5 | GO:0051973 | positive regulation of telomerase activity(GO:0051973) |
0.0 | 0.6 | GO:1904837 | beta-catenin-TCF complex assembly(GO:1904837) |
0.0 | 0.3 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.0 | 1.6 | GO:0007098 | centrosome cycle(GO:0007098) |
0.0 | 0.2 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.0 | 2.6 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.0 | 0.8 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
0.0 | 0.3 | GO:0007178 | transmembrane receptor protein serine/threonine kinase signaling pathway(GO:0007178) |
0.0 | 0.2 | GO:0032570 | response to progesterone(GO:0032570) |
0.0 | 0.5 | GO:0030317 | sperm motility(GO:0030317) |
0.0 | 0.2 | GO:1903830 | magnesium ion transmembrane transport(GO:1903830) |
0.0 | 0.2 | GO:0045494 | photoreceptor cell maintenance(GO:0045494) |
0.0 | 0.3 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
0.0 | 1.6 | GO:0018105 | peptidyl-serine phosphorylation(GO:0018105) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.3 | 70.1 | GO:0042613 | MHC class II protein complex(GO:0042613) |
3.1 | 9.2 | GO:0031251 | PAN complex(GO:0031251) |
3.1 | 15.3 | GO:0036398 | TCR signalosome(GO:0036398) |
2.7 | 8.0 | GO:0035354 | Toll-like receptor 1-Toll-like receptor 2 protein complex(GO:0035354) |
2.4 | 19.0 | GO:0032010 | phagolysosome(GO:0032010) |
2.1 | 16.6 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
2.1 | 10.3 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
1.9 | 9.6 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
1.4 | 12.8 | GO:0005579 | membrane attack complex(GO:0005579) |
1.2 | 5.0 | GO:0071062 | rough endoplasmic reticulum lumen(GO:0048237) alphav-beta3 integrin-vitronectin complex(GO:0071062) |
1.2 | 7.1 | GO:0042825 | TAP complex(GO:0042825) |
1.1 | 9.5 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
1.0 | 3.1 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
1.0 | 19.3 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.9 | 12.2 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.9 | 3.7 | GO:0097224 | sperm connecting piece(GO:0097224) |
0.8 | 4.1 | GO:0045298 | tubulin complex(GO:0045298) |
0.8 | 3.0 | GO:0005600 | collagen type XIII trimer(GO:0005600) transmembrane collagen trimer(GO:0030936) |
0.7 | 14.5 | GO:0001891 | phagocytic cup(GO:0001891) |
0.7 | 5.6 | GO:0000322 | storage vacuole(GO:0000322) |
0.7 | 4.1 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.7 | 13.5 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.6 | 4.4 | GO:0044194 | cytolytic granule(GO:0044194) |
0.6 | 7.6 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.6 | 10.9 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
0.6 | 1.8 | GO:0009330 | DNA topoisomerase complex (ATP-hydrolyzing)(GO:0009330) |
0.6 | 12.7 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.6 | 2.8 | GO:1902937 | inward rectifier potassium channel complex(GO:1902937) |
0.5 | 28.9 | GO:0001772 | immunological synapse(GO:0001772) |
0.5 | 5.8 | GO:0071014 | post-mRNA release spliceosomal complex(GO:0071014) |
0.5 | 3.8 | GO:0045179 | apical cortex(GO:0045179) |
0.5 | 2.8 | GO:1990769 | proximal neuron projection(GO:1990769) |
0.5 | 6.3 | GO:0001673 | male germ cell nucleus(GO:0001673) |
0.4 | 1.3 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.4 | 1.7 | GO:0005606 | laminin-1 complex(GO:0005606) |
0.4 | 2.1 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
0.4 | 3.7 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.4 | 1.2 | GO:1990876 | cytoplasmic side of nuclear pore(GO:1990876) |
0.4 | 11.6 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.4 | 1.1 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
0.3 | 1.0 | GO:0016935 | glycine-gated chloride channel complex(GO:0016935) |
0.3 | 2.1 | GO:0032311 | angiogenin-PRI complex(GO:0032311) |
0.3 | 12.5 | GO:0016592 | mediator complex(GO:0016592) |
0.3 | 4.3 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.3 | 4.3 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.3 | 9.6 | GO:0042629 | mast cell granule(GO:0042629) |
0.3 | 2.1 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
0.3 | 3.2 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.3 | 3.6 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.3 | 5.6 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
0.3 | 19.2 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.3 | 1.9 | GO:0097165 | nuclear stress granule(GO:0097165) |
0.3 | 3.2 | GO:0001741 | XY body(GO:0001741) |
0.3 | 0.5 | GO:0098592 | cytoplasmic side of apical plasma membrane(GO:0098592) |
0.3 | 2.4 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
0.3 | 0.8 | GO:0034685 | integrin alphav-beta6 complex(GO:0034685) |
0.3 | 3.9 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.3 | 0.5 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.2 | 3.9 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.2 | 12.4 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.2 | 27.0 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.2 | 6.6 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.2 | 0.8 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.2 | 18.4 | GO:0070821 | tertiary granule membrane(GO:0070821) |
0.2 | 8.3 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.2 | 14.9 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.2 | 5.7 | GO:0031201 | SNARE complex(GO:0031201) |
0.2 | 1.4 | GO:0005854 | nascent polypeptide-associated complex(GO:0005854) |
0.2 | 9.8 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.2 | 2.4 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.2 | 17.4 | GO:0035578 | azurophil granule lumen(GO:0035578) |
0.2 | 2.7 | GO:0042588 | zymogen granule(GO:0042588) |
0.2 | 8.2 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
0.2 | 4.3 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.2 | 1.1 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.2 | 5.0 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.1 | 1.0 | GO:1903439 | calcitonin family receptor complex(GO:1903439) amylin receptor complex(GO:1903440) |
0.1 | 5.4 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.1 | 2.5 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.1 | 3.9 | GO:0005682 | U5 snRNP(GO:0005682) |
0.1 | 1.5 | GO:0005922 | connexon complex(GO:0005922) |
0.1 | 1.9 | GO:0016442 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.1 | 0.2 | GO:0034991 | nuclear meiotic cohesin complex(GO:0034991) |
0.1 | 6.1 | GO:0001533 | cornified envelope(GO:0001533) |
0.1 | 1.1 | GO:0000800 | lateral element(GO:0000800) |
0.1 | 5.2 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.1 | 3.4 | GO:0090568 | nuclear transcriptional repressor complex(GO:0090568) |
0.1 | 12.9 | GO:0016605 | PML body(GO:0016605) |
0.1 | 0.7 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.1 | 4.1 | GO:0031904 | endosome lumen(GO:0031904) |
0.1 | 2.1 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.1 | 5.7 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.1 | 17.3 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.1 | 0.8 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.1 | 6.3 | GO:0005796 | Golgi lumen(GO:0005796) |
0.1 | 9.7 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.1 | 2.8 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.1 | 2.5 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.1 | 3.3 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.1 | 5.5 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.1 | 5.4 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.1 | 33.5 | GO:0016607 | nuclear speck(GO:0016607) |
0.1 | 2.2 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.1 | 1.9 | GO:0031231 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
0.1 | 7.2 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) potassium channel complex(GO:0034705) |
0.1 | 0.7 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
0.1 | 2.8 | GO:0035577 | azurophil granule membrane(GO:0035577) |
0.1 | 0.8 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.1 | 5.7 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.1 | 103.6 | GO:0005887 | integral component of plasma membrane(GO:0005887) |
0.1 | 0.9 | GO:0101003 | ficolin-1-rich granule membrane(GO:0101003) |
0.1 | 1.1 | GO:0031011 | Ino80 complex(GO:0031011) DNA helicase complex(GO:0033202) |
0.1 | 1.0 | GO:0097381 | photoreceptor disc membrane(GO:0097381) |
0.0 | 2.2 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.0 | 0.4 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.0 | 0.8 | GO:0005901 | caveola(GO:0005901) |
0.0 | 3.9 | GO:0031901 | early endosome membrane(GO:0031901) |
0.0 | 0.4 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.0 | 1.5 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.0 | 0.9 | GO:0034707 | chloride channel complex(GO:0034707) |
0.0 | 3.7 | GO:0032587 | ruffle membrane(GO:0032587) |
0.0 | 2.8 | GO:0001726 | ruffle(GO:0001726) |
0.0 | 38.8 | GO:0005615 | extracellular space(GO:0005615) |
0.0 | 0.4 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.0 | 2.8 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.0 | 0.2 | GO:0005587 | collagen type IV trimer(GO:0005587) |
0.0 | 4.1 | GO:0036464 | cytoplasmic ribonucleoprotein granule(GO:0036464) |
0.0 | 0.3 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.0 | 1.1 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.0 | 0.6 | GO:0005763 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.0 | 0.3 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.0 | 0.1 | GO:0008274 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.0 | 0.2 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.0 | 0.2 | GO:0031105 | septin complex(GO:0031105) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
7.1 | 28.2 | GO:0051916 | granulocyte colony-stimulating factor binding(GO:0051916) |
4.9 | 14.7 | GO:0050528 | acyloxyacyl hydrolase activity(GO:0050528) |
4.6 | 46.4 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
4.2 | 16.8 | GO:0042132 | fructose 1,6-bisphosphate 1-phosphatase activity(GO:0042132) |
4.0 | 56.2 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
3.7 | 11.2 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
3.6 | 10.9 | GO:0036134 | thromboxane-A synthase activity(GO:0004796) 12-hydroxyheptadecatrienoic acid synthase activity(GO:0036134) |
3.4 | 10.3 | GO:0005260 | channel-conductance-controlling ATPase activity(GO:0005260) |
3.4 | 17.0 | GO:0004905 | type I interferon receptor activity(GO:0004905) |
3.3 | 9.9 | GO:0016019 | peptidoglycan receptor activity(GO:0016019) |
3.2 | 12.7 | GO:0050119 | N-acetylglucosamine deacetylase activity(GO:0050119) |
2.7 | 8.0 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
2.6 | 15.4 | GO:0070892 | lipoteichoic acid receptor activity(GO:0070892) |
2.4 | 7.3 | GO:0034188 | apolipoprotein A-I receptor activity(GO:0034188) phosphatidylserine-translocating ATPase activity(GO:0090556) |
2.4 | 43.0 | GO:0019864 | IgG binding(GO:0019864) |
2.3 | 13.8 | GO:0030109 | HLA-B specific inhibitory MHC class I receptor activity(GO:0030109) |
2.2 | 17.4 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
2.1 | 6.2 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
2.0 | 16.2 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
1.9 | 19.0 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
1.7 | 8.3 | GO:0001010 | transcription factor activity, sequence-specific DNA binding transcription factor recruiting(GO:0001010) |
1.4 | 4.1 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) NAD(P)+ nucleosidase activity(GO:0050135) |
1.3 | 6.6 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
1.3 | 3.9 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
1.3 | 5.0 | GO:0015254 | glycerol channel activity(GO:0015254) urea channel activity(GO:0015265) |
1.2 | 3.7 | GO:0005148 | prolactin receptor binding(GO:0005148) |
1.2 | 8.6 | GO:0008142 | oxysterol binding(GO:0008142) |
1.2 | 4.8 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
1.2 | 6.0 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
1.2 | 7.1 | GO:0046979 | TAP2 binding(GO:0046979) |
1.2 | 7.1 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
1.2 | 9.3 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
1.1 | 3.4 | GO:1904599 | advanced glycation end-product binding(GO:1904599) |
1.1 | 6.8 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
1.1 | 5.5 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
1.1 | 4.4 | GO:0004963 | follicle-stimulating hormone receptor activity(GO:0004963) |
1.1 | 3.3 | GO:0004878 | complement component C5a receptor activity(GO:0004878) |
1.1 | 20.0 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
1.0 | 11.4 | GO:0051525 | NFAT protein binding(GO:0051525) |
1.0 | 3.1 | GO:0004609 | phosphatidylserine decarboxylase activity(GO:0004609) |
1.0 | 11.0 | GO:0042834 | peptidoglycan binding(GO:0042834) |
1.0 | 5.0 | GO:0004906 | interferon-gamma receptor activity(GO:0004906) |
0.9 | 5.6 | GO:0008269 | JAK pathway signal transduction adaptor activity(GO:0008269) |
0.9 | 2.6 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) steroid delta-isomerase activity(GO:0004769) |
0.7 | 3.0 | GO:0004031 | aldehyde oxidase activity(GO:0004031) |
0.7 | 15.9 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.7 | 2.7 | GO:1904493 | Ac-Asp-Glu binding(GO:1904492) tetrahydrofolyl-poly(glutamate) polymer binding(GO:1904493) |
0.7 | 4.1 | GO:0039552 | RIG-I binding(GO:0039552) |
0.7 | 2.0 | GO:0004087 | carbamoyl-phosphate synthase (ammonia) activity(GO:0004087) carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity(GO:0004088) |
0.7 | 8.1 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) |
0.7 | 2.7 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.6 | 11.0 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.6 | 3.2 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.6 | 1.8 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
0.6 | 4.9 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.6 | 7.3 | GO:0050700 | CARD domain binding(GO:0050700) |
0.6 | 1.8 | GO:0016434 | rRNA (cytosine) methyltransferase activity(GO:0016434) |
0.6 | 1.7 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.6 | 1.7 | GO:1904455 | ubiquitin-specific protease activity involved in negative regulation of ERAD pathway(GO:1904455) |
0.5 | 9.9 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.5 | 2.2 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
0.5 | 8.7 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.5 | 2.1 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.5 | 3.2 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.5 | 1.6 | GO:0008480 | sarcosine dehydrogenase activity(GO:0008480) oxidoreductase activity, acting on the CH-NH group of donors, flavin as acceptor(GO:0046997) |
0.5 | 8.4 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.5 | 1.5 | GO:0047325 | inositol tetrakisphosphate 1-kinase activity(GO:0047325) inositol tetrakisphosphate kinase activity(GO:0051765) inositol-1,3,4-trisphosphate 6-kinase activity(GO:0052725) inositol-1,3,4-trisphosphate 5-kinase activity(GO:0052726) inositol-1,3,4,5,6-pentakisphosphate 1-phosphatase activity(GO:0052825) inositol-1,3,4,6-tetrakisphosphate 6-phosphatase activity(GO:0052830) inositol-1,3,4,6-tetrakisphosphate 1-phosphatase activity(GO:0052831) inositol-3,4,6-trisphosphate 1-kinase activity(GO:0052835) |
0.5 | 9.3 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.5 | 1.5 | GO:0030145 | manganese ion binding(GO:0030145) |
0.5 | 2.5 | GO:0017060 | 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity(GO:0017060) |
0.5 | 4.9 | GO:0030884 | lipid antigen binding(GO:0030882) endogenous lipid antigen binding(GO:0030883) exogenous lipid antigen binding(GO:0030884) |
0.5 | 1.5 | GO:0035379 | carbon dioxide transmembrane transporter activity(GO:0035379) |
0.5 | 1.5 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.5 | 1.9 | GO:0008823 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.5 | 1.4 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.5 | 2.3 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.5 | 1.8 | GO:0005477 | pyruvate secondary active transmembrane transporter activity(GO:0005477) |
0.5 | 1.8 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.5 | 2.3 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.5 | 1.8 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.5 | 4.1 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.4 | 7.2 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.4 | 3.6 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.4 | 1.8 | GO:0001855 | complement component C4b binding(GO:0001855) |
0.4 | 2.6 | GO:0015185 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.4 | 13.0 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.4 | 32.5 | GO:0004004 | ATP-dependent RNA helicase activity(GO:0004004) |
0.4 | 1.7 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
0.4 | 6.6 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.4 | 3.2 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.4 | 1.2 | GO:0005174 | CD40 receptor binding(GO:0005174) |
0.4 | 68.8 | GO:0003823 | antigen binding(GO:0003823) |
0.4 | 4.1 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.4 | 1.1 | GO:0005549 | odorant binding(GO:0005549) |
0.4 | 1.4 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.4 | 2.1 | GO:0003796 | lysozyme activity(GO:0003796) |
0.4 | 3.9 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.3 | 1.7 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.3 | 3.4 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.3 | 4.7 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.3 | 2.7 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.3 | 4.7 | GO:0036374 | glutathione hydrolase activity(GO:0036374) |
0.3 | 3.3 | GO:0031433 | telethonin binding(GO:0031433) |
0.3 | 2.3 | GO:0004952 | dopamine neurotransmitter receptor activity(GO:0004952) |
0.3 | 39.9 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
0.3 | 1.3 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
0.3 | 2.0 | GO:0050692 | DBD domain binding(GO:0050692) |
0.3 | 2.8 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.3 | 3.7 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.3 | 4.2 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.3 | 3.0 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.3 | 1.2 | GO:0004909 | interleukin-1, Type I, activating receptor activity(GO:0004909) |
0.3 | 1.8 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.3 | 2.7 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.3 | 3.0 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.3 | 5.0 | GO:0004559 | alpha-mannosidase activity(GO:0004559) |
0.3 | 3.1 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.3 | 1.1 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
0.3 | 5.3 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
0.3 | 0.8 | GO:0050429 | calcium-dependent phospholipase C activity(GO:0050429) |
0.3 | 8.4 | GO:0005123 | death receptor binding(GO:0005123) |
0.3 | 2.7 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.3 | 6.4 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.3 | 2.9 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.3 | 1.0 | GO:0019976 | interleukin-2 receptor activity(GO:0004911) interleukin-2 binding(GO:0019976) |
0.3 | 0.8 | GO:0047757 | chondroitin-glucuronate 5-epimerase activity(GO:0047757) |
0.2 | 25.3 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.2 | 3.4 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.2 | 3.4 | GO:0031402 | sodium ion binding(GO:0031402) |
0.2 | 0.7 | GO:0015439 | heme-transporting ATPase activity(GO:0015439) |
0.2 | 2.6 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.2 | 0.9 | GO:0055102 | lipase inhibitor activity(GO:0055102) |
0.2 | 3.9 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.2 | 2.5 | GO:0008430 | selenium binding(GO:0008430) |
0.2 | 4.1 | GO:0070330 | aromatase activity(GO:0070330) |
0.2 | 36.9 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.2 | 1.1 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.2 | 1.3 | GO:0004522 | ribonuclease A activity(GO:0004522) |
0.2 | 2.2 | GO:0015385 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) |
0.2 | 1.0 | GO:0016933 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.2 | 1.9 | GO:0050072 | m7G(5')pppN diphosphatase activity(GO:0050072) |
0.2 | 5.6 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.2 | 1.0 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.2 | 5.9 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.2 | 3.8 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.2 | 2.5 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.2 | 2.1 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.2 | 1.3 | GO:0032393 | MHC class I receptor activity(GO:0032393) |
0.2 | 1.7 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.2 | 2.8 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.2 | 6.6 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.2 | 0.5 | GO:0015333 | peptide:proton symporter activity(GO:0015333) proton-dependent peptide secondary active transmembrane transporter activity(GO:0022897) |
0.2 | 1.0 | GO:0045029 | UDP-activated nucleotide receptor activity(GO:0045029) |
0.2 | 1.6 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.2 | 1.6 | GO:0003720 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.2 | 1.1 | GO:0015662 | ATPase activity, coupled to transmembrane movement of ions, phosphorylative mechanism(GO:0015662) |
0.2 | 2.6 | GO:0005537 | mannose binding(GO:0005537) |
0.2 | 16.2 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.2 | 0.8 | GO:0017018 | myosin phosphatase activity(GO:0017018) |
0.2 | 6.4 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.1 | 1.2 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.1 | 3.5 | GO:0070403 | NAD+ binding(GO:0070403) |
0.1 | 1.0 | GO:0097643 | amylin receptor activity(GO:0097643) |
0.1 | 0.4 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.1 | 1.0 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
0.1 | 1.9 | GO:0036122 | BMP binding(GO:0036122) |
0.1 | 6.8 | GO:0030331 | estrogen receptor binding(GO:0030331) |
0.1 | 11.0 | GO:1990782 | protein tyrosine kinase binding(GO:1990782) |
0.1 | 3.0 | GO:0008201 | heparin binding(GO:0008201) |
0.1 | 1.9 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.1 | 3.0 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
0.1 | 4.0 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.1 | 0.8 | GO:0004447 | iodide peroxidase activity(GO:0004447) |
0.1 | 2.0 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.1 | 4.8 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.1 | 4.7 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.1 | 1.9 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.1 | 2.7 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.1 | 5.5 | GO:0050699 | WW domain binding(GO:0050699) |
0.1 | 2.2 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.1 | 1.0 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.1 | 2.7 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.1 | 6.0 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.1 | 1.2 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.1 | 0.8 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.1 | 0.9 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.1 | 1.3 | GO:0045159 | myosin II binding(GO:0045159) |
0.1 | 1.3 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.1 | 18.5 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.1 | 2.3 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.1 | 1.1 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.1 | 3.3 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.1 | 4.9 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
0.1 | 0.5 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.1 | 1.4 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
0.1 | 1.2 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.1 | 2.7 | GO:0031489 | myosin V binding(GO:0031489) |
0.1 | 6.4 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.1 | 4.6 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.1 | 4.4 | GO:0043621 | protein self-association(GO:0043621) |
0.1 | 17.9 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.1 | 3.5 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.1 | 0.7 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.1 | 2.3 | GO:0042287 | MHC protein binding(GO:0042287) |
0.1 | 4.4 | GO:0003899 | DNA-directed RNA polymerase activity(GO:0003899) RNA polymerase activity(GO:0034062) |
0.1 | 0.7 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.1 | 0.6 | GO:0030274 | LIM domain binding(GO:0030274) |
0.1 | 7.8 | GO:0005262 | calcium channel activity(GO:0005262) |
0.1 | 0.5 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.1 | 1.7 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
0.1 | 29.2 | GO:0000982 | transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0000982) |
0.1 | 0.2 | GO:0036033 | mediator complex binding(GO:0036033) |
0.1 | 0.5 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.1 | 10.8 | GO:0005178 | integrin binding(GO:0005178) |
0.1 | 5.9 | GO:0019903 | protein phosphatase binding(GO:0019903) |
0.1 | 0.6 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.1 | 0.6 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.1 | 0.8 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.1 | 1.2 | GO:0035064 | methylated histone binding(GO:0035064) |
0.1 | 0.4 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.1 | 0.7 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.1 | 0.6 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.1 | 2.5 | GO:0097110 | scaffold protein binding(GO:0097110) |
0.1 | 1.0 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.1 | 1.1 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.1 | 0.3 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.1 | 2.6 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.1 | 3.9 | GO:0016782 | transferase activity, transferring sulfur-containing groups(GO:0016782) |
0.1 | 1.1 | GO:0001848 | complement binding(GO:0001848) |
0.0 | 0.0 | GO:0004618 | phosphoglycerate kinase activity(GO:0004618) |
0.0 | 0.6 | GO:0004386 | helicase activity(GO:0004386) |
0.0 | 0.6 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.0 | 0.5 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.0 | 0.4 | GO:0043225 | anion transmembrane-transporting ATPase activity(GO:0043225) |
0.0 | 1.0 | GO:0001221 | transcription cofactor binding(GO:0001221) |
0.0 | 2.4 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.0 | 2.5 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.0 | 0.3 | GO:0030021 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
0.0 | 2.5 | GO:0019905 | syntaxin binding(GO:0019905) |
0.0 | 0.2 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.0 | 0.5 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.0 | 1.5 | GO:0008083 | growth factor activity(GO:0008083) |
0.0 | 0.7 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
0.0 | 1.3 | GO:0008026 | ATP-dependent helicase activity(GO:0008026) purine NTP-dependent helicase activity(GO:0070035) |
0.0 | 0.8 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.0 | 30.5 | GO:0003700 | nucleic acid binding transcription factor activity(GO:0001071) transcription factor activity, sequence-specific DNA binding(GO:0003700) |
0.0 | 0.3 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.0 | 1.6 | GO:0043022 | ribosome binding(GO:0043022) |
0.0 | 0.8 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.0 | 0.9 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
0.0 | 2.3 | GO:0005179 | hormone activity(GO:0005179) |
0.0 | 0.4 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.0 | 0.2 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.0 | 1.7 | GO:0003712 | transcription cofactor activity(GO:0003712) |
0.0 | 1.3 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.0 | 1.1 | GO:0030332 | cyclin binding(GO:0030332) |
0.0 | 1.3 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.0 | 1.7 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.0 | 0.8 | GO:0008009 | chemokine activity(GO:0008009) |
0.0 | 0.3 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.0 | 0.4 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.0 | 0.2 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.0 | 0.2 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
0.0 | 0.9 | GO:0001664 | G-protein coupled receptor binding(GO:0001664) |
0.0 | 0.3 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.0 | 0.3 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.0 | 0.7 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) |
0.0 | 0.2 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.9 | 26.4 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.8 | 25.4 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.7 | 21.2 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.7 | 17.6 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.7 | 9.1 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.7 | 73.0 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.6 | 31.7 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.6 | 3.2 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.6 | 31.7 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.5 | 27.2 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.5 | 3.3 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.5 | 22.4 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
0.4 | 23.4 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.4 | 16.0 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.4 | 9.5 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.3 | 6.1 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.2 | 11.5 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.2 | 3.4 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.2 | 5.8 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.2 | 3.8 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.2 | 9.5 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.2 | 10.8 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.2 | 15.2 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.2 | 4.2 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.2 | 9.2 | PID CDC42 PATHWAY | CDC42 signaling events |
0.2 | 2.6 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.1 | 4.4 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.1 | 9.5 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.1 | 3.4 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.1 | 6.0 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.1 | 6.9 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.1 | 2.8 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.1 | 3.7 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.1 | 4.4 | PID ARF6 PATHWAY | Arf6 signaling events |
0.1 | 1.8 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.1 | 3.7 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.1 | 2.8 | PID RHOA PATHWAY | RhoA signaling pathway |
0.1 | 4.3 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.1 | 2.7 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.1 | 2.9 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.1 | 1.7 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.1 | 1.2 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.1 | 1.7 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.1 | 3.1 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.1 | 1.4 | ST ADRENERGIC | Adrenergic Pathway |
0.1 | 2.4 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.1 | 1.5 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.1 | 17.6 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.1 | 2.0 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.1 | 2.4 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.1 | 11.4 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.1 | 0.9 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.1 | 1.1 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.1 | 2.0 | PID ATR PATHWAY | ATR signaling pathway |
0.1 | 0.9 | PID RAS PATHWAY | Regulation of Ras family activation |
0.1 | 3.5 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.0 | 15.2 | NABA MATRISOME ASSOCIATED | Ensemble of genes encoding ECM-associated proteins including ECM-affilaited proteins, ECM regulators and secreted factors |
0.0 | 0.2 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.0 | 2.4 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.0 | 0.6 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.0 | 1.7 | PID ATM PATHWAY | ATM pathway |
0.0 | 5.4 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.0 | 0.3 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.0 | 0.6 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.0 | 0.5 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.0 | 0.4 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.0 | 44.9 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
1.6 | 15.6 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
1.5 | 7.6 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
1.3 | 34.1 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
1.1 | 19.3 | REACTOME DEFENSINS | Genes involved in Defensins |
1.1 | 50.7 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.9 | 75.6 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.8 | 8.3 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
0.7 | 17.0 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.7 | 2.9 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.7 | 30.8 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.7 | 1.4 | REACTOME SHC MEDIATED SIGNALLING | Genes involved in SHC-mediated signalling |
0.6 | 9.4 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.6 | 31.5 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.5 | 9.9 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.5 | 15.3 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.5 | 18.7 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.5 | 5.0 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.4 | 6.2 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.4 | 6.5 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.4 | 7.8 | REACTOME NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | Genes involved in Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways |
0.4 | 9.3 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.4 | 12.7 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.3 | 32.1 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.3 | 13.6 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.3 | 2.2 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.3 | 4.7 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.3 | 1.9 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.3 | 12.6 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.3 | 43.4 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.3 | 3.9 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
0.3 | 9.9 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.2 | 5.6 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.2 | 17.6 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.2 | 6.9 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.2 | 2.6 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.2 | 4.2 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.2 | 12.7 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.2 | 9.5 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.2 | 5.6 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.2 | 3.4 | REACTOME TAK1 ACTIVATES NFKB BY PHOSPHORYLATION AND ACTIVATION OF IKKS COMPLEX | Genes involved in TAK1 activates NFkB by phosphorylation and activation of IKKs complex |
0.2 | 4.1 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.2 | 5.7 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.2 | 5.3 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.2 | 7.6 | REACTOME IL 2 SIGNALING | Genes involved in Interleukin-2 signaling |
0.2 | 2.9 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.2 | 2.8 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.2 | 3.2 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.2 | 1.9 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.1 | 3.7 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.1 | 6.3 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.1 | 5.8 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.1 | 1.1 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.1 | 2.2 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.1 | 1.8 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.1 | 4.3 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.1 | 1.5 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.1 | 3.5 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.1 | 6.4 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.1 | 1.8 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.1 | 0.9 | REACTOME SIGNALLING TO RAS | Genes involved in Signalling to RAS |
0.1 | 2.0 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.1 | 1.0 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.1 | 5.5 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.1 | 1.4 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.1 | 4.2 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.1 | 0.7 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.1 | 4.2 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.1 | 1.1 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.1 | 25.4 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
0.1 | 2.7 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.1 | 1.6 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.1 | 3.0 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.1 | 3.0 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.1 | 1.3 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.1 | 2.5 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.1 | 0.6 | REACTOME OPSINS | Genes involved in Opsins |
0.1 | 1.2 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.1 | 0.8 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
0.1 | 7.6 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.1 | 1.4 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.1 | 1.1 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.0 | 0.9 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.0 | 1.3 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.0 | 1.5 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.0 | 1.1 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.0 | 0.6 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.0 | 1.1 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.0 | 1.0 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.0 | 0.7 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.0 | 1.0 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.0 | 0.2 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.0 | 0.6 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.0 | 0.5 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.0 | 1.2 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.0 | 0.5 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.0 | 0.9 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.0 | 0.4 | REACTOME PHOSPHORYLATION OF THE APC C | Genes involved in Phosphorylation of the APC/C |
0.0 | 0.3 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.0 | 0.3 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.0 | 0.2 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.0 | 1.1 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |